Mike Stratton
Director/Board Member at Wellcome Trust Sanger Institute
Profile
Mike Stratton is the founder of Quotient Therapeutics Ltd., which was founded in 2022.
He is currently the Director at Wellcome Trust Sanger Institute.
Mike Stratton active positions
Companies | Position | Start |
---|---|---|
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | - |
Former positions of Mike Stratton
Companies | Position | End |
---|
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Mike Stratton